Research Ethics Board approves amendment to Canadian Treatments for COVID-19 (CATCO) Trial to include LSALT Peptide (Metablok)

NEXT STORY
Quipt Adds $13 Million in Annualized Revenue, $1.6 Million in Net Income, Anticipated $2.9 Million of Adjusted EBITDA Post Integration and 15,000 New Active Patients With Acquisition of Indiana Based Company
PREV STORY
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SEASONS HOSPICE OPENS NEW HOSPICE INPATIENT CENTER IN HENRY FORD WYANDOTTE HOSPITAL

Wyandotte, Michigan, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Seasons Hospice & Palliative Care is ...

author_avatar
NASDAQ Market News

Rheumatology Community Responds to MACRA Proposed Rule

ATLANTA, April 28, 2016 (GLOBE NEWSWIRE) -- "The Centers for Medicare & Medicaid Services ...

author_avatar
NASDAQ Market News

Amendment to Sections 5 and 9(1) of the Articles of Association of Orion Corporation entered in the Trade Register

ORION CORPORATION         STOCK EXCHANGE RELEASE 6 APRIL 2017 at 9.00 EET                      Amendment to Sections ...

author_avatar
NASDAQ Market News